Luminal B
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (NCT03875573) | Jules Bordet Institute | 2019-11-06 |
| Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. (NCT03356860) | Grand Hôpital de Charleroi | 2017-04-13 |
| Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients (NCT03860740) | Spanish Breast Cancer Research Group | 2016-06-01 |
Track Luminal B automatically
Every clearance here is in the API, with alerts when new ones post.